WuXi Biologics Granted Highest Negligible-Risk ESG Rating from Morningstar Sustainalytics

Company Overview - WuXi Biologics is a leading global Contract Research, Development, and Manufacturing Organization (CRDMO) that provides end-to-end solutions for biologics from concept to commercialization [6][8] - The company employs over 12,000 skilled employees across multiple countries including China, the United States, Ireland, Germany, and Singapore [7] ESG Rating and Recognition - WuXi Biologics has achieved the highest negligible-risk tier in the Morningstar Sustainalytics ESG rating, placing it in the top 1% globally [3][9] - The company has been recognized as an Industry and Regional ESG Top-Rated Company for five consecutive years [3][9] - WuXi Biologics has received multiple accolades for its sustainability efforts, including a MSCI AAA rating, EcoVadis Platinum Medal, and inclusion in the Dow Jones Sustainability Indices [4] Commitment to Sustainability - The company emphasizes sustainability as a cornerstone of long-term business growth and is focused on driving green technology innovations [8] - WuXi Biologics collaborates with stakeholders to promote responsible practices and create positive social and environmental impacts throughout the value chain [10]